Latest UK News
Methicillin-resistant Staphylococcus aureus (MRSA) has become a serious problem, forcing doctors to turn to antibiotics other than penicillin or penicillin derivatives, or to different drug cocktails, which are often less effective in treating hospital and community based infections.
MRC-supported researchers are among the 56 scientists elected as new EMBO Members.
Ambitious delivery plans published today outline how UK Research and Innovation (UKRI), which includes MRC, will work with its partners to ensure that world-leading research and innovation continues to flourish in the UK.
Congratulations to the people closely connected with the MRC who have been recognised in the 2019 Queen’s Birthday Honours list.
The MRC has launched a new pilot funding scheme today aiming to support researchers through difficult transition periods in their careers.
The annual MRC Festival of Medical Research takes place from 13-23 June 2019. It involves a wide range of free public activities showcasing MRC-funded research. The programme of MRC Festival activities launched today.
MRC is one of twelve funders investing a total of £25 million into understanding and influencing the social, economic and environmental factors that affect our health. The investment marks the first ever funding round of the UK Prevention Research Partnership (UKPRP).
MRC-supported scientists are among the 50 distinguished medical researchers elected as Fellows of the Academy of Medical Sciences.
The MRC is to run a competition process on behalf of Health Data Research UK, to create Digital Innovation Hubs: centres of excellence dedicated to pioneering the use of health data for research and innovation.
The study from the MRC LMB published in the journal Cell is the first to identify insulin as a primary signal that helps communicate the timing of meals to the cellular clocks located across our body, commonly known as the body clock.
The MRC’s 2019 Max Perutz Science Writing Award is now open.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, according to a new paper co-authored by MRC researchers.
Professor Dame Anna Dominiczak has been appointed as MRC Health Innovation Champion.
MRC scientists have isolated therapeutic antibodies from healthy volunteers exposed to the Ebola vaccine but not Ebola virus itself, suggesting that protective therapies could be developed from people who are disease-free.
By building capacity and capability in public health research, a report shows how the legacy of a UK-wide network of centres of excellence has helped fuel future public health and prevention research.
Cutting edge projects have received £23 million of government funding under the Biomedical Catalyst, it was announced today. The MRC invested nearly £13.5 million in a number of innovative projects.
MRC Laboratory of Molecular Biology researchers reveal atomic structures of the abnormal tau filaments associated with chronic traumatic encephalopathy, a head injury-associated neurodegenerative disease, differ in structure from those seen in Alzheimer’s disease.
A nine to 11-month treatment regimen is as effective in treating multi-drug resistant tuberculosis (MDR-TB) as the 20 to 24-month regimen recommended in 2011 WHO guidelines, according to new research conducted by a team of researchers, including MRC scientists.
A vast tranche of new UK Biobank genetic data becomes available to health researchers today, offering an unprecedented resource to enhance understanding of human biology and aid in therapeutic discovery.
The debilitating behaviours and all-consuming thoughts, which affect people with severe obsessive compulsive disorder (OCD), could be significantly improved with targeted deep brain stimulation, according to the findings of an MRC-funded study.